Delivery Order SPE2DR25D3202-SPE2DR26F8F5J
Award Date 3/25/26
Potential Completion Date 3/26/26
Potential Value $2.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $1,863.44 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml).</p> <p>The order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is March 16, 2026. Pricing is firm fixed price with no set-aside used.</p>
- <p>The Defense Logistics Agency issued a $1,961.81 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml). The order is placed against the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed-price terms and no set-aside, with an ultimate completion date of March 19, 2026.</p>
- <p>The Defense Logistics Agency issued a $2,086.61 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for Quillivant XR 25 mg/5 ml suspension (120 ml), with ultimate completion on March 19, 2026.</p> <p>The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a $1,162.22 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order has a firm...
- The Defense Logistics Agency issued a $2,433.68 delivery order to Amerisourcebergen Drug Corp on March 24, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml). The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The ultimate completion date is March 25, 2026....
- The Defense Logistics Agency issued a $2,405.02 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Quillivant XR 25 mg/5 ml suspension (120 ml). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 9, 2026. Pricing is...
- The Defense Logistics Agency issued a $1,058.04 delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for Quillivant XR 25 mg/5 ml suspension (60 ml), with ultimate completion on March 23, 2026. The order is issued under the parent DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA....
- The Defense Logistics Agency issued a $1,302.06 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Quillivant XR 25 mg/5 ml suspension (150 ml). This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply to military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate...
- The Defense Logistics Agency issued a $3,017.86 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Quillivant XR 25 mg/5 ml suspension (120 ml). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $1,250.98 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for Quillivant XR 25 mg/5 ml suspension (120 ml), with ultimate completion by March 16, 2026. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken,...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8F5JDelivery Order
The Defense Logistics Agency issued a $2,659.58 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Quillivant XR 25 mg/5 ml suspension (150 ml), with an ultimate completion date of March 26, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used.
Generated 6/23/26, 10:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/24/26 |